Company profile: Cormatrix Cardiovascular
1.1 - Company Overview
Company description
- Provider of biomaterial medical devices that harness the body’s ability to repair damaged heart tissue, including the CorTricuspid ECM Valve for surgical management of tricuspid valve disease in adult and pediatric patients, and the FDA-cleared CorPatch epicardial repair product for supporting and repairing heart areas weakened after myocardial infarction.
Products and services
- Biomaterial Cardiac Device Development: CorMatrix architects custom-engineered biomaterial devices harnessing the body’s repair of damaged heart tissues
- CorPatch Epicardial Repair Product: FDA-cleared epicardial device fabricated for placement to support and repair myocardial infarction-weakened heart areas
- CorTricuspid ECM Valve: Biomaterial-based valve engineered for surgical management of tricuspid valve disease and dysfunction in adult and pediatric patients
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cormatrix Cardiovascular
Adagio Medical
HQ: United States
Website
- Description: Provider of research and development focused on creating treatments for cardiovascular diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adagio Medical company profile →
CathVision
HQ: Denmark
Website
- Description: Provider of novel hardware, software and data science solutions to guide ablation therapy of cardiac arrhythmia, including the ECGenius System for high-fidelity, low-noise electrogram acquisition; CARDIALYTICS for automated electrogram interpretation; PVI Analyzer and Signal Complexity visualization tools; and FaST Mapping, an AI-based algorithm in development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CathVision company profile →
Millipede Medical
HQ: United States
Website
- Description: Provider of a percutaneous, catheter-based solution for mitral valve repair and treatment of mitral and tricuspid regurgitation, restoring health and expanding options for physicians and patients globally.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Millipede Medical company profile →
CardiAQ Valve Technologies
HQ: United States
Website
- Description: Provider of innovative heart valve replacement solutions, initially focused on transcatheter mitral valve implantation (TMVI), a minimally invasive catheter-based procedure for replacing the heart's mitral valve.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CardiAQ Valve Technologies company profile →
AccessClosure
HQ: United States
Website
- Description: Provider of access site management products for vascular closure during interventional and diagnostic procedures, including the Mynx delivery system, a vascular closure device that seals the arteriotomy using a water-soluble, extravascular sealant.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AccessClosure company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cormatrix Cardiovascular
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cormatrix Cardiovascular
2.2 - Growth funds investing in similar companies to Cormatrix Cardiovascular
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cormatrix Cardiovascular
4.2 - Public trading comparable groups for Cormatrix Cardiovascular
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →